Novel acylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H.
申请公布号
EP2910569(B1)
申请公布日期
2016.10.05
申请号
EP20140198511
申请日期
2009.03.13
申请人
NOVO NORDISK A/S
发明人
HOEG-JENSEN, THOMAS;TAGMOSE, TINA MØLLER;KJELDSEN, THOMAS BØRGLUM;GLENDORF, TINE;GARIBAY, PATRICK W.;MADSEN, PETER;JAKOBSEN, PALLE;KODRA, JÁNOS TIBOR;PETERSEN, JACOB STEN
